Cagrillintide 5MG

Description

What is Cagrilintide?

Cagrilintide is a synthetic, long-acting amylin analogue investigated in amylin-receptor and metabolic research. This description interprets the catalogue spelling ‘Cagrillintide’ as cagrilintide; confirm the chemical identity against the supplier documentation.

Check the supplier specification and any available batch-specific analytical documentation for identity, composition and suitability for your laboratory method.

Published study findings and evidence limits

Human trial evidence

A randomised phase 2 trial reported greater body-weight reduction with cagrilintide than placebo in adults with overweight or obesity. Gastrointestinal symptoms and injection-site reactions were reported. This is evidence about cagrilintide as studied, conditional on confirmation of the compound identity in this listing.

Sources: Cagrilintide phase 2 trial (2021).

Are benefits proven for this product? No clinical benefit has been established for the research material sold in this listing. Positive results for a characterised study formulation do not validate this batch, its safety or its suitability for human use. Research findings are provided for scientific context.

For research purposes only. Supplied exclusively for laboratory research and analytical use. Not for human or animal consumption, injection, therapeutic, diagnostic or cosmetic use. This product is not supplied as a medicine, food or dietary supplement. Information on this page describes research context and does not establish safety or efficacy for use in people or animals.